"#COVID-19 Disease Burden in the Omicron Variant-Dominated Endemic Phase: Insights from the #ROUTINE-COV19 Study Using Real-World German Statutory Health Insurance Data" - check out our #publication in #Viruses. pubmed.ncbi.nlm.nih.gov/40143351/ NCBI TU München #Research #Munich

🤩Super excited our branched #PancreaticCancer #Organoids to capture tumour heterogeneity made it on the cover of Nature Biomedical Engineering 🙏🏼nature.com/natbiomedeng/v… TU München VomLaborInDiePraxis @TUMKlinikum Aristeidis Papargyriou Reichert Lab

What a great day! 😁 Very happy to see the latest cover of Nature Biomedical Engineering featuring our paper from my PhD work with Maximilian Reichert TU München on #Organoids capturing tumour heterogeneity!! Thanks to an amazing team! 🤩 Thanks to Ella Marushchenko for the cover ☺️! nature.com/articles/s4155…

Last reminder Today, 5pm, in #Munich & via Zoom: Lecture "Targeting #pancreaticcancer progression, metastasis and treatment resistance guided by intravital imaging" by Dr. David Herrmann, Garvan Institute of Medical Research. We will be happy to welcome you to this talk! med2.mri.tum.de/en/seminar_ser…